Point of Care for INR Yvonne Koolman, Nicole Keech, Amy Nelson-Long & Sue Vansteel.

Slides:



Advertisements
Similar presentations
The Home INR Study (THINRS): Home INR Monitoring as Effective as Clinic-Based Care AK Jacobson, MD American Heart Association 2008 Scientific Sessions:
Advertisements

Disease State Management The Pharmacist’s Role
The Value of Medication Therapy Management Services
Warfarin Sodium (Anticoagulant) Therapy Training 03/10/2015.
Prophylaxis of Venous Thromboembolism
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
POC INR Testing Rural and Remote Session 2015 CADTH SYMPOSIUM Janice Mann MD Knowledge Mobilization, CADTH.
Drug Utilization Review (DUR)
Introduction to Evidence Based Medicine Pediatric Clerkship LSUHSC.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.
What can we do to cut down the time it takes to give a clot dissolving drug (tPA)?
Debbie Schmidt RN, MCSE Conference 2009 Nurse 2.0 Engaging the Healthcare Consumer Mobile Wound Care.
Improving the Outcomes of Oral Anticoagulation: Home Monitoring of Warfarin Therapy Jack Ansell, M.D. Lenox Hill Hospital, NY September 22, 2009 Disclosures.
Managing Warfarin Drug Interactions: The Bayview Experience DAWN Users Group, November 2002 Charles H. Twilley, MBA, PharmD Johns Hopkins Bayview Medical.
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/12/12 Warfarin Monitoring If inpatient, consider monitoring.
Medication Adherence in Heart Failure University of Central Florida Tessa Dillon.
Antiplatelet or Anticoagulant: Do They Have the same Efficacy? University of Central Florida Deborah Andrews RN, BSN.
Dr.F Eslamipour DDS.MS Orthodontist Associated professor Department of Oral Public Health Isfahan University of Medical Science.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Neurology APTT, PTT, PT, INR. Neurology APTT, PTT, PT, INR.
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
Bryan Bray, Pharm.D., CPP Chief Operating Officer Medication Management, LLC Vice President of Clinical Services Piedmont Pharmaceutical Care Network,
The Value of Medication Therapy Management Services.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Elizabeth Kinnucan Bethany Perry Jessica Way.  Practice based on research findings “Evidence based practice provides opportunities for nursing care to.
Stop the Clot ™ David Henry and Tom Hogan Cardiovascular and Renal Drugs Advisory Committee U.S. Food and Drug Administration Adelphi,
Clinical Pharmacy Part 2
Prevention of Recurrent Venous Thromboembolism N Engl J Med Apr ;348(15) : PREVENT (Warfarin) Trial.
Rivaroxaban for Prevention of Venous Thromboembolism After Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study Kwong L, Lees.
Finding Relevant Evidence
DVT Prevention and Anticoagulant Management
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
Clinical Writing for Interventional Cardiologists.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Lung Volume Reduction Surgery and Quality of Life Amy Burker ALHE 4060/ Masini April 22, 2007.
Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) PI: Jan Hirsch, RPh, PhD Carol M. Mangione, MD, MSPH Barbara A. Levey.
A Randomized Trial of Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism Schulman S et al. Proc ASH 2011;Abstract 205.
EBP Team Project Jessica Alred, April Dye, Tiffany Scroggins, Leisa Taylor Auburn Montgomery.
Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy R. Rossini, G. Musumeci,
ASSESSING THE FEASIBILITY OF ANTIBIOTIC MANAGEMENT SERVICES THROUGH PROSPECTIVE EVALUATION ABSTRACT PURPOSE: The inappropriate and unnecessary use of antibiotics.
Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.
Anti-Xa versus aPTT for therapeutic Anticoagulation
Is the conscientious explicit and judicious use of current best evidence in making decision about the care of the individual patient (Dr. David Sackett)
Credit Valley Hospital Patient Flow Purpose of Initiative To improve the flow of admitted patients from the emergency room to the medical units and improve.
Alarm Sensors: Evaluating the Effectiveness in Reducing Elderly Inpatient Falls Jenna Barnwell, RN Jessica Cantrell, RN Sabrina George, RN Whitney Holman,
Patient Population Nursing-Pharmacy Collaboration on Medication Reconciliation: A Novel Approach to Information Management Michelle Silas MPH, BSN, RN,
Maintaining Arterial Catheters with Normal Saline Catherine Williams MSN student.
Warfarin-Specific Medication Charts Do they have a place in Aged Care Facilities? Margaret Jordan a,b Judy Mullan a, Victoria Traynor a a. University of.
Local Enhanced Service Care bundles Dr Andy Kilpatrick, Clinical Lead.
SECONDARY PREVENTION IN HEART DISEASE CATHY QUICK AUBURN UNIVERSITY/AUBURN MONTGOMERY EBP III.
Response to An Initial Dose of Warfarin in Thai Patients Undergoing Long-Term Anticoagulant Therapy Weerayuth Saelim R.Ph. 2 nd year Pharmacy resident.
Use of White Noise Machine in Long-Term Care Patients Jamie Wilson COHP 450.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Top 5 papers of Prehospital care Recommended by Torpong.
The Efficacy of Dabigatran versus Warfarin for Stroke Prevention in Patients With Atrial Fibrillation: Systematic Review Karim Bouferrache Pacific University.
1st International Online BioMedical Conference (IOBMC 2015)
Paediatric Cardiac Pharmacist Bristol Royal Hospital for Children
Polypharmacy In Adults: Small Test of Change
Aug, 2016.
Fort Hays State University, Department of Nursing
Management of Type II Diabetes
UNT Health Clinical Pharmacist Services
Pharmacogenomics Genes and Drugs.
GHS Outpatient Enoxaparin Program
Pharmacy practice and the healthcare system Ola Ali Nassr
Volume 379, Issue 9813, Pages (January 2012)
Point-of-Care vs Laboratory INR Testing to Optimize Anticoagulation Management.
Stroke Protocols Ensure Efficient Patient Intake, Diagnosis, Treatment
Presentation transcript:

Point of Care for INR Yvonne Koolman, Nicole Keech, Amy Nelson-Long & Sue Vansteel

Point of Care for INR Introduction Large proportion of patients, from long term care, acute care and home care settings require anticoagulant (blood thinning) medications. These medications include: o Warfarin sodium or Coumadin o Lovenox o Aspirin o Enoxaparin (administered IV).

Why INR The"Gold Standard" monitoring patients on anticoagulants is laboratory based venipuncture for INR and PT Sub-therapeutic anticoagulation: can increase the risk of clot formation, thereby increasing the risk of stroke or venous thromboembolism Supra-therapeutic anticoagulation: increases the risk for bleeding Donaldson, 2010

Purpose Critically analyze available literature to determine the relevance of Point of Care INR testing for inpatient and outpatient settings. To demonstrate POC INR testing is cost- effect, increases responsiveness to management of anticoagulation therapy and improves patient satisfaction.

Problem Lengthy turnaround time for the lab results has been demonstrated to cause delays in management of anticoagulation therapy. Decreased compliance with getting labs drawn and medication changes Patients unable to obtain transportation to the lab Decreased patient satisfaction related to lab wait time. Affects the patient's quality of life

Hypothesis A review of literature will demonstrate POC INR testing is relevant in outpatient and inpatient setting. Use of POC INR testing is cost-effective and decreases the time from results to management of anticoagulation therapy.

POC for INR POC testing requires reduced amount of blood to perform test thus the ability to use a finger prick instead of a venipuncture Point of Care (POC) testing- blood specimen is obtained from the patient with a handheld device. Results are reported within minutes.

Point of Care for INR Point of Care (POC) INR testing devices has been utilized in outpatient settings Benefits Instant results Reduce delays in management of anticoagulation therapy Prevent adverse reaction Cost-effective Improved patient satisfaction

Literature Review Article 1 Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data Authors sought to clarify the value of self- monitoring of oral anticoagulation Of 1357 abstracts, 11 trials were included in the study for a total of 6416 participants. Study indicated a significant reduction in thromboembolic events in the self-monitoring groups

Article 1 cont Study did not show significant reductions in major hemorrhage or death Participants younger than 55 years and participants with mechanical heart valves showed a striking reduction in thrombotic events Analysis of the very elderly (age > 85 years) showed no significant adverse effects of the intervention for all outcomes

Managing Anticoagulation Clinic Article 2 Clinic Provides guidance for establishing anticoagulation clinics using a POC INR device. Computerized system to determine dosage based on results.

Article 2 Benefits Autonomy in patients own treatment. Increased self-management. Patient self testing

Article 2 Criteria for selecting POC INR device Ease of use. Speed at which results are produced. Reliability of device in terms of: o Evidence-based purchasing o International sensitivity Index (ISI) of close to 1.0 in line with World Health Organization recommendation

Disease focused model compared to nurse managed model study 90% of study participants remained within target range after 6 months of going to the clinic All PT/INR done with POC testing in a nurse clinic during the study Patients are able to get test results and new orders within their 15 minutes visits No patients were admitted to the hospital related to their INR being out of therapeutic range

Article 3 cont. 74 patients INR results were followed in the nurse clinic for 6 months The use of POC testing assists with immediate results and the ability to educate related to the new dose thus improving overall medication management and health

Comparing Point of Care International Normalised Ratio testing with laboratory testing methods in a cardiac inpatient setting Article 4 POC testing was demonstrated to a viable method for INR testing in an outpatient setting. Lack of research related to POC INR in inpatient setting A prospective comparison study to analyze the efficacy of POC for INR in an inpatient setting was conducted

Article 4 cont. 117 paired results of laboratory and POC INR results were compared POC INR were blinded and not used for management of Warfarin dosing Outcome of the study revealed there was close agreement in the results with significant correlation With established guideline laboratory INR testing can be safely substituted using POC INR in an inpatient setting

Recommendations Patients in an acute care, home care, long term care, and outpatient settings can benefit from the use of POC testing for PT/INR results to improve medication management and health. Further research into the the possible scenarios where POC INR use would be beneficial to patient satisfaction and outcomes is necessary.

Conclusion There is a potential to create change in acute care, long term care and outpatient setting with management of anticoagulation therapy. Lab INR testing can be safely replaced with POC INR testing utilizing guidelines and protocols.

Conclusion Comparison of INR from a lab and POC were significantly correlated. Enhanced responsiveness for managing anticoagulation therapy is an outcome of POC INR in an inpatient and outpatient setting. Additional benefits include “cost saving, increased patient comfort, and reduce handling errors” (Giles et al., 2009 pg. 3085)

References Giles, Michelle T., Vicki Parker, Heather Bevan, and Ian MR Wright. Comparing point of care International Normalized Ratio testing with laboratory testing methods in a cardiac inpatient population. Journal of Clinical Nursing 19: CINAHL. Burns, N. & Groves S. K. (2011) Understanding nursing research: Building an evidence-based. Maryland Heights, MO: Elsevier Donaldson, M., Sullivan, J., Norbeck, A Comparison of International Normalized Ratios provided by two point-of-care devices and laboratory- based venipuncture in a pharmacist-managed anticoagulation clinic. American Journal of Health-System Pharmacists- Vol. 67. DOI /ahp j Gesechwinger, R.F. (2004). Anticoagulation Therapy a Success with Patient- focused Model. The Nurse Practitioner, 29(8),

Reference Heneghan, C., Ward, A., Perera, R., Bankhead, C., Fuller, A., Stevens, R., Bradford, K., Tyndel, S., Alonso- Coelo, P., Ansell, J., Beyeth, R., Brenardo, A., Cristensen, T., Cromheecke, M., Edson, E., Fitzmaurice, D., Gadisseur, A., Garcia-Alamino, J., Gardiner, C., Hasenkam, M., Jacobson, A., Kaatz, S., Kamali, F., Khan, T., Knight, E., Kortke, H., Levi, M., Matchar, D., Menendez- Jandula, B., Rakovac, I., Schaefer, C., Siebenhofer, A., Souto, J., Sunderji, R., Gin, K., Shalansky, K., Voller, H., Wagner, O., Zittermann, A., The Self- Monitoring Trialist Collaboration (2012). Self- monitoring of oral anticoagulation: systematic review and meta- analysis of individual patient data. The Lancet. (379). DOI: /S (11) Murray RGN, MSc, PhD, E. (2007). Managing Anticoagulation. Practice Nurse Arp 6; 33(7) Retrieved May 30, 2012, from CINAHL ( ).